Todos os posts

Revisão do estado da arte | Revascularização na doença arterial coronariana estável.

19 Jun, 2022 | 14:39h

Revascularization in stable coronary artery disease – The BMJ

---

Revisão sistemática | Inibidores da Janus quinase para o tratamento de COVID-19.

19 Jun, 2022 | 14:38h

Janus kinase inhibitors for the treatment of COVID‐19 – Cochrane Library

Resumo: Are systemic Janus kinase inhibitors an effective treatment for people with COVID-19? – Cochrane Library

---

[Preprint] Estudo randomizado | Ivermectina não beneficia pacientes com COVID-19 leve a moderada no ambiente ambulatorial.

19 Jun, 2022 | 14:36h

Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial – medRxiv

Comentário: Study finds no benefit to taking ivermectin for COVID-19 symptoms – Duke University

---

Em um estudo de doadores de sangue nos EUA, a combinação de soroprevalência do SARS-CoV-2 oriunda de infecção ou de vacinação atingiu 94,7%.

19 Jun, 2022 | 14:35h

Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021 – JAMA

 

Comentário no Twitter

In this study of US blood donations, the combined seroprevalence from #SARSCoV2 infection or vaccination reached 94.7% by December 2021. https://t.co/OiHICuWDo4

— JAMA (@JAMA_current) June 13, 2022

 

---

Segurança comparativa das vacinas BNT162b2 e mRNA-1273 em uma coorte nacional de veteranos nos EUA.

19 Jun, 2022 | 14:27h

Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans – JAMA Internal Medicine

Comentário: Few differences in safety profiles of Moderna, Pfizer COVID-19 vaccines – Harvard T.H. Chan School of Public Health

 

Comentário no Twitter

1/
TODAY: We compared the safety of #COVID19 mRNA vaccines in the largest healthcare system in the US.

TAKE-HOME MESSAGE: Both Moderna and Pfizer vaccines are quite safe. If interested in vaccination, you can confidently use whichever one is available.https://t.co/fFIlXwH5Qv

— Miguel Hernán (@_MiguelHernan) June 13, 2022

 

---

Breve resumo dos principais fatos atuais e recomendações | Linfadenopatia regional após vacinação contra COVID-19 em pacientes com ou sem suspeita de câncer de mama.

19 Jun, 2022 | 14:21h

Regional Lymphadenopathy Following COVID-19 Vaccination in Patients with or Suspicious of Breast Cancer: A Quick Summary of Current Key Facts and Recommendations – Korean Journal of Radiology

Conteúdos relacionados:

2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) – Insights into Imaging

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance – The BMJ

Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination – European Radiology

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care – European Journal of Cancer

---

Posicionamento científico | Direção diagnóstica do cuidado terapêutico para alergias e intolerâncias alimentares pediátricas.

19 Jun, 2022 | 14:17h

Diagnostic therapeutic care pathway for pediatric food allergies and intolerances in Italy: a joint position paper by the Italian Society for Pediatric Gastroenterology Hepatology and Nutrition (SIGENP) and the Italian Society for Pediatric Allergy and Immunology (SIAIP) – Italian Journal of Pediatrics

---

Diretriz de recomendação | Diagnóstico e tratamento da mastocitose sistêmica.

19 Jun, 2022 | 14:16h

Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel – Hematology, Transfusion and Cell Therapy

---

Atualização de diretriz ASCO | Terapia sistêmica do melanoma.

19 Jun, 2022 | 14:15h

Systemic Therapy for Melanoma: ASCO Guideline Rapid Recommendation Update – Journal of Clinical Oncology

---

Diretriz ASGE sobre o rastreamento de câncer pancreático em indivíduos com suscetibilidade genética.

19 Jun, 2022 | 14:14h

ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations – Gastrointestinal Endoscopy

Comentário: New guidelines for pancreatic cancer screening – Beth Israel Deaconess Medical Center

 

Comentário no Twitter

Sawhney et al share "ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations." https://t.co/P6OtmhXr2D pic.twitter.com/vDHWfKCAiN

— GIE (@GIE_Journal) May 26, 2022

 

---